References
- Tanner MJ. Molecular and cellular biology of the enythrocyte anion exchanger (AE1). Semin Hematol. 1993;30:34–57.
- Yawata Y, Kanzaki A, Yawata A, et al. Hereditary red cell membrane disorders in Japan: their genotypic and phenotypic features in 1014 cases studied. Hematology. 2001;6:399–422. doi: https://doi.org/10.1080/10245332.2001.11746596
- Smythe J, Spring F, Gardner B, et al. Monoclonal antibodies recognizing epitopes on the extracellular face and intracellular N-terminus of the human erythrocyte anion transporter (band 3) and their application to the analysis of South East Asian ovalocytes. Blood. 1995;85:2929–2936.
- Nakanishi H, Kanzaki A, Yawata A, et al. Ankyrin gene mutations in Japanese patients with hereditary spherocytosis. Int J Hematol. 2001;73:54–63. doi: https://doi.org/10.1007/BF02981903
- Bruce LJ, Beckmaum R, Ribeiro ML, et al. A band 3-based macrocomplex of integral and peripheral proteins in the RBC membrane. Blood. 2003;101:4180–4188. doi: https://doi.org/10.1182/blood-2002-09-2824
- Hamasaki N, Yamamoto M. Red blood cell function and blood storage. Vox Sang. 2000;79:191–197. doi: https://doi.org/10.1046/j.1423-0410.2000.7940191.x
- Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685. doi: https://doi.org/10.1038/227680a0
- King MJ, Jepson MA, Guest A, et al. Detection of hereditary pyropoikilocytosis by the eosin-5-maleimide (EMA)-binding test is attributable to a marked reduction in EMA-reactive transmembrane proteins. Int J Lab Hematol. 2011;33:205–211. doi: https://doi.org/10.1111/j.1751-553X.2010.01270.x
- King M-J, Telfer P, MacKinnon H, et al. Using the eosin-5’-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis. Cytometry B Clin Cytom. 2008;74B:244–250. doi: https://doi.org/10.1002/cyto.b.20413
- Yang X, Wu H, Kobayashi T, et al. Enhanced ionization of phosphorylated peptides during MALDI TOF mass spectrometry. Anal Chem. 2004;76:1532–1536. doi: https://doi.org/10.1021/ac035203v
- Palek J, Jarolim P. Clinical expression and laboratory detection of red blood cell membrane protein mutations. Semin Hematol. 1993;30:249–283.
- Hassoun H, Vassiliadis JN, Murray J, et al. Molecular basis of spectrin deficiency in beta spectrin Durham. A deletion within beta spectrin adjacent to the ankyrin-binding site precludes spectrin attachment to the membrane in hereditary spherocytosis. J Clin Invest. 1995;96:2623–2629. doi: https://doi.org/10.1172/JCI118327
- Satchwell TJ, Bell AJ, Hawley BR, et al. Severe ankyrin-R deficiency results in impaired surface retention and lysosomal degradation of RhAG in human erythroblasts. Haematologica. 2016;101:1018–1027. doi: https://doi.org/10.3324/haematol.2016.146209
- Walensky LD, Nala M, Lux SE. Disorders of the red blood cell membrane. In: Handin RI, Lux SE, Stossel TP, editors. Blood: Principles and practice of hematology, 2nd ed. Philadelphia (PA): Lippincott Williams Wilkins; 2003. p. 1709–1858.
- Eber S, Lux SE. Hereditary spherocytosis – defects in proteins that connect the membrane skeleton to the lipid bilayer. Semin Hematol. 2004;41:118–141. doi: https://doi.org/10.1053/j.seminhematol.2004.01.002
- Bolton-Maggs PH, Stevens RF, Dodd NJ, et al. Guidelines for the diagnosis and management of hereditary spherocytosis. Br J Haematol. 2004;126:455–474. doi: https://doi.org/10.1111/j.1365-2141.2004.05052.x
- King MJ, Garçon L, Hoyer JD, et al. ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders. Int J Lab Hematol. 2015;37:304–325. doi: https://doi.org/10.1111/ijlh.12335